Melichar B, Malirova E, Bures J, Komarkova O, Kolesar J, Rejchrt S, Fixa B
Second Department of Internal Medicine, Charles University Medical School, Hradec Kralove, Czech Republic.
FEMS Immunol Med Microbiol. 1995 Feb;10(3-4):335-8. doi: 10.1111/j.1574-695X.1995.tb00052.x.
Neopterin, a pteridine compound produced by macrophages activated by interferon-gamma, is widely used to assess the activation of cellular immunity. An elevation in serum or urinary neopterin reflects immune activation in many different disorders, including viral infections, cancer, autoimmune diseases or acute myocardial infarction, but less attention has been paid to neopterin concentration in other biological fluids. The aim of the present study was to examine neopterin concentration in gastric juice. An association with the presence of Helicobacter pylori, a bacterium linked to the most common disorders of upper digestive tract, was also investigated. Gastric juice was obtained at endoscopy from 61 patients. Neopterin was determined by a radioimmunoassay and the presence of H. pylori was examined by urease test. The macroscopic finding of bile in gastric juice was associated with significantly higher neopterin levels compared to patients where no bile was noted (15.5 +/- 15.6 vs. 2.1 +/- 3.0 nmol/l, P < 0.001). However, similar concentrations were observed in the H. pylori positive and H. pylori negative patients (7.6 +/- 12.0 vs. 11.1 +/- 14.9 nmol/l). Even in the absence of macroscopic bile contamination, no significant difference could be found between the infected and uninfected patients (2.3 +/- 3.2 vs. 1.3 +/- 1.9 nmol/l), and the patients with duodenal ulcer and normal findings (3.8 +/- 4.6 vs 1.6 +/- 1.9 nmol/l). The contamination of gastric juice with bile represents the limitation for the use of neopterin as a marker of immune activation in the gastric mucosa. Rather than an index of immune activation, gastric juice neopterin concentration represents a marker of duodenogastric reflux.
新蝶呤是一种由γ-干扰素激活的巨噬细胞产生的蝶啶化合物,广泛用于评估细胞免疫的激活情况。血清或尿液中新蝶呤水平升高反映了多种不同疾病中的免疫激活,包括病毒感染、癌症、自身免疫性疾病或急性心肌梗死,但其他生物体液中的新蝶呤浓度较少受到关注。本研究的目的是检测胃液中的新蝶呤浓度。同时还研究了其与幽门螺杆菌(一种与上消化道最常见疾病相关的细菌)存在与否的关联。在内镜检查时从61例患者获取胃液。采用放射免疫分析法测定新蝶呤,并通过尿素酶试验检测幽门螺杆菌的存在。与未发现胆汁的患者相比,胃液中肉眼可见胆汁的患者新蝶呤水平显著更高(15.5±15.6对2.1±3.0 nmol/l,P<0.001)。然而,幽门螺杆菌阳性和阴性患者的新蝶呤浓度相似(7.6±12.0对11.1±14.9 nmol/l)。即使在没有肉眼可见胆汁污染的情况下,感染和未感染患者之间(2.3±3.2对1.3±1.9 nmol/l)以及十二指肠溃疡患者和检查结果正常患者之间(3.8±4.6对1.6±1.9 nmol/l)均未发现显著差异。胃液被胆汁污染限制了新蝶呤作为胃黏膜免疫激活标志物的应用。胃液新蝶呤浓度并非免疫激活指标,而是十二指肠-胃反流的标志物。